Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8867)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 21, 2022 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sabaté JM, Iglicki F. Effect of Bifidobacterium longum 35624 on disease severity and quality of life in patients with irritable bowel syndrome. World J Gastroenterol 2022; 28(7): 732-744 [PMID: 35317278 DOI: 10.3748/wjg.v28.i7.732] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i7/732.htm |
| Number | Citing Articles |
| 1 |
V. T. Ivashkin, I. V. Maev, O. P. Alekseeva, S. A. Alekseenko, N. V. Korochanskaya, E. A. Poluektova, V. I. Simanenkov, A. S. Trukhmanov, I. B. Khlynov, V. V. Tsukanov, O. S. Shifrin, T. L. Lapina, R. V. Maslennikov, A. I. Ulyanin. Determination of Probiotics Prescription Indications in Patients with Irritable Bowel Syndrome (Materials of the Expert Council and Literature Review). Russian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 32(2): 9 doi: 10.22416/1382-4376-2022-32-2-9-18
|
| 2 |
Xiaomin Hu, Ziying Han, Ruilin Zhou, Wan Su, Liang Gong, Zihan Yang, Xiao Song, Shuyang Zhang, Huijun Shu, Dong Wu. Altered gut microbiota in the early stage of acute pancreatitis were related to the occurrence of acute respiratory distress syndrome. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1127369
|
| 3 |
Stephanie Maxine Ross. Irritable Bowel Syndrome. Holistic Nursing Practice 2024; 38(2): 120 doi: 10.1097/HNP.0000000000000639
|
| 4 |
M. A. Livzan, O. V. Gaus. Modulation of microbiota as a target in the management of patients with irritable bowel syndrome. Meditsinskiy sovet = Medical Council 2023; (18): 18 doi: 10.21518/ms2023-366
|
| 5 |
Samira Ait Abdellah, Julien Scanzi, Caroline Gal, Marc Martin, Marc Beck, Veronica Ojetti. Lactobacillus gasseri LA806 Supplementation in Patients with Irritable Bowel Syndrome: A Multicenter Study. Journal of Clinical Medicine 2022; 11(24): 7446 doi: 10.3390/jcm11247446
|
| 6 |
Liping Liu, Qin Wu, Yuping Chen, Huiling Ren, Qi Zhang, Hengyue Yang, Wenying Zhang, Tingyu Ding, Shujie Wang, Yan Zhang, Yun Liu, Jihu Sun. Gut microbiota in chronic pain: Novel insights into mechanisms and promising therapeutic strategies. International Immunopharmacology 2023; 115: 109685 doi: 10.1016/j.intimp.2023.109685
|
| 7 |
Dmitry N. Andreev, Igor V. Maev. The role of probiotics in current algorithms for the treatment of irritable bowel syndrome: A review. Consilium Medicum 2023; 25(5): 336 doi: 10.26442/20751753.2023.5.202131
|
| 8 |
N. V. Korochanskaya. The microbiome of patients with irritable bowel syndrome: pathophysiology and applied aspects. Meditsinskiy sovet = Medical Council 2022; (14): 107 doi: 10.21518/2079-701X-2022-16-14-107-112
|
| 9 |
Marion Lenoir, Jörg Wienke, Frédérique Fardao-Beyler, Nadine Roese. An 8-Week Course of Bifidobacterium longum 35624® Is Associated with a Reduction in the Symptoms of Irritable Bowel Syndrome. Probiotics and Antimicrobial Proteins 2023; doi: 10.1007/s12602-023-10151-w
|
| 10 |
Cristina Maria Marginean, Mihaela Popescu, Andrei Ioan Drocas, Sergiu Marian Cazacu, Radu Mitrut, Iulia Cristina Marginean, George Alexandru Iacob, Marian Sorin Popescu, Anca Oana Docea, Paul Mitrut. Gut–Brain Axis, Microbiota and Probiotics—Current Knowledge on Their Role in Irritable Bowel Syndrome: A Review. Gastrointestinal Disorders 2023; 5(4): 517 doi: 10.3390/gidisord5040043
|
| 11 |
V. V. Tsukanov, A. V. Vasyutin, Ju. L. Tonkikh. Efficacy of probiotics for the treatment of irritable bowel syndrome. Meditsinskiy sovet = Medical Council 2022; (15): 119 doi: 10.21518/2079-701X-2022-16-15-119-126
|
| 12 |
Chang Kyo Oh, Jae Keun Park, Yu Jin Kim, Jin Bae Kim. Efficacy and safety of human gut-derived multi-strain probiotics in patients with irritable bowel syndrome: A prospective open-label observation study. Medicine 2023; 102(34): e34899 doi: 10.1097/MD.0000000000034899
|
| 13 |
Olga I. Solovyeva, Anna S. Nekrasova, Iulia G. Topalova, Viktoriia A. Ponomarenko, Daredzhan B. Tsurtsumiia, Inna G. Ilyashevich. Long-term probiotic administration for irritable bowel syndrome: a legal need. Terapevticheskii arkhiv 2023; 95(8): 679 doi: 10.26442/00403660.2023.08.202378
|
| 14 |
Mingliang Zhao, Zhenxing Ren, Aihua Zhao, Yajun Tang, Junliang Kuang, Mengci Li, Tianlu Chen, Shouli Wang, Jieyi Wang, Huiheng Zhang, Jijun Wang, Tianhong Zhang, Jiahui Zeng, Xiaohua Liu, Guoxiang Xie, Penghong Liu, Ning Sun, Tianhao Bao, Tongtong Nie, Jingchao Lin, Ping Liu, Yuanyi Zheng, Xiaojiao Zheng, Tiemin Liu, Wei Jia. Gut bacteria-driven homovanillic acid alleviates depression by modulating synaptic integrity. Cell Metabolism 2024; doi: 10.1016/j.cmet.2024.03.010
|